The Pharmacy Board will be moving to a temporary location while the office building is being renovated. The office will be down during the move, from February 28 the to March 4th. The new address is 3812 N. Santa Fe Suite 300, Oklahoma City, OK 73118.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Board of Pharmacy proposed to adopt the following rules. Written comments may be submitted via email to pharmacy.rulemaking@bop.oregon.gov before 4:30 p.m. on March 29 rulemaking hearing.
Also in Oregon, the Department of Human Services announced plans to lift mask requirements for indoor public spaces and schools on March 19.
Finally in Oregon, Gov. Kate Brown (D) announced that she will lift the state’s COVID-19 Emergency Declaration effective April 1.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Department of Human Services released a new bulletin announcing SARS-CoV-2 Monoclonal Antibody Product Updates that includes pharmacy reimbursement rates and billing procedures.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Department of Health has provided an update on COVID-19 oral antiviral therapeutics in the state, specifically, Paxlovid® by Pfizer and Molnupiravir by Merck, with guidance for pharmacies requesting them.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
The Health and Human Services Commission’s (HHSC) Vendor Drug Program (VDP) is accepting comments until March 10th on the March 2022 draft Specialty Drug List. Stakeholders should send submissions on the Specialty Drug Submission Spreadsheet.
Also in Texas, the HHSC adopted a final rule establishing a process for Medicaid Managed Care organizations (MCOs) to recoup certain overpayments made to health care providers in connection with missing electronic visit verification information. The rule also requires MCOs to give providers at least 60 days to correct a deficiency.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Board of Pharmacy published its February 2022 newsletter. Highlights include the impact of HB 178 on pharmacy practice, pharmacy staff supervision, insulin refills, Controlled Substance Database (CDS) updates when returning controlled substances to stock, CDS and the DSP12 Transmission Form of Rx Origin Code and SafeUT Frontline app.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Legislature’s crossover deadline for bills to pass one chamber to be eligible for further consideration was met on February 15. The following bills of interest to pharmacy met the deadline:
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Gov. Jay Inslee (D) issued a proclamation removing the statewide indoor mask mandate effective February 18, 2022.
Also in Washington, legislation twice amended that NACDS opposed that mandates prescription label translations, unanimously passed the House earlier this month. This week it was approved by the Senate Health and Long-Term Care and Rules Committees, and now goes to the full Senate for review. (ESHB 1852)
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Alabama Medicaid Agency will host a virtual online seminar to provide an update to the cost-effectiveness methodology to Alabama Coordinated Health Network (ACHN) provider groups. The purpose of the online seminar is to provide an overview and answer questions on the modified cost effectiveness methodology that will take effect on April 15, 2022, check write.
Also in Alabama, the Board of Pharmacy has issued a proposed rule regarding non-disciplinary penalties for late renewal of license, permit, registration, certification, or any similar document issued.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.